Industry Projects
LATEST INDUSTRY PROJECTS
Abatacept (Orencia) was developed by Bristol-Myers-Squibb for the treatment of rheumatoid arthritis (RA). It is a biologic drug that contains a selective co-stimulation modulator.
Xiaflex to Treat Dupuytren's Contracture
Xiaflex is the first drug indicated for treating Dupuytren's contracture. The drug...
Xiaflex is the first drug indicated for treating Dupuytren's contracture. The drug...
Tasigna (Nilotinib)
Tasigna (nilotinib) is indicated for treating Philadelphia chromosome positive chronic...
Tasigna (nilotinib) is indicated for treating Philadelphia chromosome positive chronic...
- Abatacept - Treatment for Rheumatoid Arthritis NEW
- Abiraterone – Prostate Cancer Therapy
- Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
- Actemra - Biological Therapy for Rheumatoid Arthritis (RA)
- Afamelanotide - Photo-Protective Drug for Treatment of Light-Related Skin Disorders
- Afinitor – Anti-Cancer Therapy UPDATED
- Alemtuzumab – Potential in Multiple Sclerosis
- Almorexant - Agent for Treatment of Sleep Disorders
- AM103 – Experimental Treatment for Respiratory Diseases
- AMR101 – Omega-3-Based Treatment for Hypertriglyceridaemia, United Kingdom
- APD125 - Therapy for Insomnia
- Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for Chronic Obstructive Pulmonary Disease (COPD)
- ASA404 Vascular Disrupting Agent for Solid Tumours
- Avastin (bevacizumab) - Angiogenesis Inhibitor and Cancer Therapy
- Benlysta - Lupus Treatment UPDATED
- Bifeprunox - Atypical Antipsychotic Drug
- Blinatumomab - Treatment for Non-Hodgkin's Lymphoma and Acute Lymphoblastic Leukaemia
- BNC105 – Vascular Targeting Agent for Cancer Treatment
- Boceprevir – Experimental Drug for Chronic Hepatitis C Infection
- Byetta - First-in-Class Incretin Mimetic for Type 2 Diabetes
- Caprospinol, Therapy for Alzheimer's Disease (AD)
- Ceftobiprole - Injectable Anti-MRSA Cephalosporin Antibiotic
- Celvapan – H1N1 Pandemic Influenza Vaccine
- Cepheid Xpert vanA Test Kit, USA
- Cerovive - Neuroprotectant for the Treatment of Acute Ischaemic Stroke
- Cervarix – Cervical Cancer Vaccine
- Cetilistat - Investigational Drug for Obesity
- Cilansetron - New Treatment for IBS
- Dalvabancin - Second-Generation Glycopeptide for Serious Gram-Positive Infections
- Darapladib - Selective Lp-PLA2 Inhibitor for Prevention of Atherosclerosis
- Dasatinib - Tyrosine Kinase Inhibitor for Chronic Myeloid Leukaemia (CML)
- Denosumab - Therapy for Prevention and Treatment of Osteoporosis
- Dimebon - Investigational Compound Indicated for the Treatment of Alzheimer's and Huntington's disease
- Doripenem - A New Broad-Spectrum Carabapenem Antibiotic
- Edoxaban, Oral Anticoagulant, Japan
- Elotuzumab – Anti-CS1 Antibody for Multiple Myeloma
- Enbrel – Immunosuppressant for Treatment of Rheumatoid Arthritis
- Erbitux (Cetuximab) - Biological Cancer Therapy
- ETC-216 - Phospholipid Therapy for Coronary Heart Disease (CHD) Patients
- Exanta - Oral Direct Thrombin Inhibitor for the Prevention and Treatment of Venous Thromboembolism
- Exubera - Inhaled Insulin for Type 1 and Type 2 Diabetes
- Fablyn (Lasofoxifene) - Investigational SERM for the Prevention and Treatment of Osteoporosis
- Fampridine-SR – Treatment for Multiple Sclerosis
- Fidaxomicin – Narrow-Spectrum Antibiotic for Clostridium Difficile Infection
- Fingolimod - Novel Therapy for Multiple Sclerosis
- Florbetaben - 18F-Radiolabelled Tracer For Diagnosis of Alzheimer's Disease
- Fludase - Experimental Antiviral Drug for Influenza
- Flurizan – Anti-Amyloid Drug for Treatment of Alzheimer’s Disease
- Idraparinux - Investigational Agent for the Treatment and Prevention of Thromboembolic Events
- Iloperidone - Atypical Antipsychotic for Schizophrenia
- Iluvien Diabetic Macular Edema Treatment, USA
- INCB9471 – CCR5 Antagonist for Treatment of HIV Infection
- Indinavir – First-Generation HIV Protease Inhibitor
- Influenza A (H1N1) Monovalent Vaccine by Sanofi Pasteur
- Istaroxime - Agent for Congestive Heart Failure
- Ixempra (Ixapebilone) – New Cancer Therapy
- Lamictal – Approved Treatment for Epilepsy and Bipolar, USA
- Lexapro – Treatment for Major Depressive Disorder in Adolescents
- Licofelone - Novel Analgesic and Anti-Inflammatory Agent for Osteoarthritis
- Liraglutide - Next-Generation Antidiabetic Medication
- Lorcaserin, Investigational Oral Anti-Obesity Drug
- Lurasidone - Treatment for Schizophrenia and Bipolar Disorder, Japan
- LY2140023 – Treatment of Schizophrenia
- Lyrica (Pregabalin) - New Gabapentinoid with Wide Clinical Application
- M6G, A New Morphine Derivative For Post-Operative Pain Relief
- Maraviroc - Therapy for Treatment of HIV Infection
- Merck Isentress - Emerging Therapy for Treatment of HIV Infection
- Mirapex (Pramipexole) - Treatment for Parkinson's Disease, Germany
- MOR103 - Antibody for the Treatment of Rheumatoid Arthritis, Germany
- Motavizumab - New Biological Therapy for RSV Prevention
- Multaq - Investigational Agent for the Treatment of Cardiac Arrhythmia
- Mylinax - Novel Therapy for the Treatment of Multiple Sclerosis
- Pandemrix - Adjuvanted H1N1 Influenza Vaccine
- Panflu.1 – Single-Shot Vaccine Against H1N1 Influenza
- Paxil – SSRI for the Treatment of Major Depressive Disorders, USA
- Peramivir - Neuraminidase Inhibitor for Treatment of Influenza
- Pertuzumab –Cancer Therapy
- Phenserine - Next Generation AChE Inhibitor for Alzheimer's Disease UPDATED
- Plectasin NZ2114 - Novel Microbial Agent
- Pradaxa – Oral Direct Thrombin Inhibitor
- Prasugrel - Investigational Antiplatelet Agent
- Prexige - COX-2 Inhibitor for the Relief of Pain and Inflammation
- Rasagiline - Second-Generation MAO-B Inhibitor for the Treatment of Parkinson's Disease
- Rasilez – Innovative Treatment for Hypertension
- Rember - Therapy for Alzheimer's Disease
- Restanza – Oral Antibiotic for Treatment of Community-Acquired Pneumonia
- Revatio (Sildenafil) - Treatment for Pulmonary Arterial Hypertension, USA
- Rezular – Oral Treatment for IBS
- Rupintrivir - Experimental Treatment for the Common Cold
- T-705 - Antiviral Drug for Influenza
- Tamiflu - Oral Anti-Viral Treatment Agent
- Taranabant CB1 Receptor Inverse Agonist for Obesity
- Tarceva - Small Molecule EGFR-Tyrosine Kinase Inhibitor for Cancer
- Tasigna (Nilotinib) – Treatment for Philadelphia Chromosome Positive Chronic Myeloid Leukaemia, USA
- TB-402 – Therapeutic Monoclonal Antibody for VTE AND AF
- Telbivudine - Investigational Drug for Chronic Hepatitis B Infection
- Tesmilifene - Chemopotentiator for Cancer Therapies
- Tesofensine - Anti-Obesity Medication
- TRA-SCH-530348 -Oral Antiplatelet Agent
- Trastuzumab - Treatment for HER2-Positive Advanced Recurrent Gastric Cancer, USA NEW
- Treximet - Next-Generation Treatment for Migraine
- Tygacil - Broad-Spectrum Antibiotic for Empiric Treatment of Serious Infections
- Tykerb - Dual Tyrosine Kinase Inhibitor for the Treatment of Solid Tumours
- Tysabri - Therapeutic Monoclonal Antibody (MAb) for the Treatment of Multiple Sclerosis
